Encompass Health Corp (EHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5B 5B 7.5B Q4 '17: 3.9B Q1 '18: 4B Q2 '18: 4.1B Q3 '18: 4.2B Q4 '18: 4.3B Q1 '19: 4.4B Q2 '19: 4.4B Q3 '19: 4.5B Q4 '19: 4.6B Q1 '20: 4.7B Q2 '20: 4.6B Q3 '20: 4.6B Q4 '20: 4.6B Q1 '21: 4.7B Q2 '21: 4.9B Q3 '21: 4.7B Q4 '21: 4.6B Q1 '22: 4.4B Q2 '22: 4.2B Q3 '22: 4.3B Q4 '22: 4.3B Q1 '23: 4.4B Q2 '23: 4.6B Q3 '23: 4.7B Q4 '23: 4.8B Q1 '24: 5B Q2 '24: 5.1B Q3 '24: 5.2B Q4 '24: 5.4B Q1 '25: 5.5B Q2 '25: 5.7B Q3 '25: 5.8B Q4 '25: 5.9B Q1 '26: 6.1B Q2 '26: 6.2B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 250M 500M 750M Q4 '15: 485.7M Q1 '16: 524.3M Q2 '16: 551.1M Q3 '16: 578.1M Q4 '16: 588.1M Q1 '17: 591M Q2 '17: 582.1M Q3 '17: 579.1M Q4 '17: 578.3M Q1 '18: 581.2M Q2 '18: 597.2M Q3 '18: 606.5M Q4 '18: 555.2M Q1 '19: 572.3M Q2 '19: 567.6M Q3 '19: 564.3M Q4 '19: 612.1M Q1 '20: 604.3M Q2 '20: 536.9M Q3 '20: 536.8M Q4 '20: 563.9M Q1 '21: 547.6M Q2 '21: 609.2M Q3 '21: 599.5M Q4 '21: 559.6M Q1 '22: 548.1M Q2 '22: 529.9M Q3 '22: 516M Q4 '22: 539.5M Q4 '15 Q4 '16 Q4 '17 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22

Net Income TTM

0 350M 700M 1.1B Q4 '09: 94.8M Q1 '10: 90.6M Q2 '10: 143.4M Q3 '10: 158.4M Q4 '10: 899M Q1 '11: 938.1M Q2 '11: 912.7M Q3 '11: 937.9M Q4 '11: 208.7M Q1 '12: 173.1M Q2 '12: 197.9M Q3 '12: 188M Q4 '12: 185M Q1 '13: 192.1M Q2 '13: 310.6M Q3 '13: 321.7M Q4 '13: 323.6M Q1 '14: 319M Q2 '14: 236.9M Q3 '14: 228.8M Q4 '14: 222M Q1 '15: 217.8M Q2 '15: 177.6M Q3 '15: 178.2M Q4 '15: 183.1M Q1 '16: 198.6M Q2 '16: 218.3M Q3 '16: 229.3M Q4 '16: 247.6M Q1 '17: 256.4M Q2 '17: 256.8M Q3 '17: 261M Q4 '17: 271.1M Q1 '18: 288.1M Q2 '18: 316.9M Q3 '18: 339.6M Q4 '18: 292.3M Q1 '19: 310.8M Q2 '19: 310.2M Q3 '19: 319.2M Q4 '19: 358.7M Q1 '20: 343.4M Q2 '20: 285.7M Q3 '20: 265.8M Q4 '20: 284.2M Q1 '21: 304.5M Q2 '21: 384.3M Q3 '21: 406.6M Q4 '21: 412.2M Q1 '22: 392.4M Q2 '22: 327.8M Q3 '22: 273.2M Q4 '22: 271M Q1 '23: 271.2M Q2 '23: 313.9M Q3 '23: 353.8M Q4 '23: 352M Q1 '24: 376.8M Q2 '24: 399.5M Q3 '24: 422.4M Q4 '24: 455.7M Q1 '25: 494.7M Q2 '25: 522.7M Q3 '25: 541M Q4 '25: 566.2M Q1 '26: 609.2M Q2 '26: 621M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 500M 1B 1.5B Q2 '10: 350M Q3 '10: 307.9M Q4 '10: 331M Q1 '11: 335.7M Q2 '11: 316M Q3 '11: 280.3M Q4 '11: 342.7M Q1 '12: 334.2M Q2 '12: 379.6M Q3 '12: 431.7M Q4 '12: 411.5M Q1 '13: 451.9M Q2 '13: 443.3M Q3 '13: 478.7M Q4 '13: 470.3M Q1 '14: 456M Q2 '14: 478.6M Q3 '14: 475.6M Q4 '14: 444.9M Q1 '15: 439.8M Q2 '15: 414.7M Q3 '15: 438.4M Q4 '15: 502M Q1 '16: 569.6M Q2 '16: 618.9M Q3 '16: 633.2M Q4 '16: 640.2M Q1 '17: 651.4M Q2 '17: 650.4M Q3 '17: 647.7M Q4 '17: 658.3M Q1 '18: 693.8M Q2 '18: 711.8M Q3 '18: 735.4M Q4 '18: 762.4M Q1 '19: 706M Q2 '19: 682.2M Q3 '19: 598.1M Q4 '19: 635.3M Q1 '20: 504.7M Q2 '20: 581.6M Q3 '20: 640.6M Q4 '20: 704.7M Q1 '21: 833.9M Q2 '21: 867.5M Q3 '21: 871.7M Q4 '21: 715.8M Q1 '22: 776.2M Q2 '22: 764.9M Q3 '22: 657.4M Q4 '22: 705.8M Q1 '23: 714.8M Q2 '23: 676.9M Q3 '23: 822M Q4 '23: 850.8M Q1 '24: 861.7M Q2 '24: 872.4M Q3 '24: 925M Q4 '24: 1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Free Cash Flow TTM

0 200M 400M 600M Q2 '10: 292M Q3 '10: 250M Q4 '10: 268.2M Q1 '11: 273.9M Q2 '11: 250.6M Q3 '11: 210.4M Q4 '11: 242.4M Q1 '12: 219.7M Q2 '12: 228.2M Q3 '12: 274.8M Q4 '12: 270.7M Q1 '13: 308.2M Q2 '13: 316.3M Q3 '13: 283.6M Q4 '13: 275.1M Q1 '14: 234.3M Q2 '14: 262.9M Q3 '14: 313.3M Q4 '14: 274M Q1 '15: 307.8M Q2 '15: 287M Q3 '15: 316.2M Q4 '15: 373.6M Q1 '16: 427.5M Q2 '16: 465.4M Q3 '16: 476.1M Q4 '16: 462.5M Q1 '17: 463.9M Q2 '17: 444.2M Q3 '17: 428.2M Q4 '17: 432.5M Q1 '18: 449.3M Q2 '18: 477.1M Q3 '18: 493.8M Q4 '18: 507.9M Q1 '19: 439.1M Q2 '19: 380.7M Q3 '19: 255.2M Q4 '19: 262.9M Q1 '20: 121.1M Q2 '20: 198.4M Q3 '20: 271.9M Q4 '20: 311.9M Q1 '21: 425.8M Q2 '21: 428.6M Q3 '21: 402.8M Q4 '21: 191.2M Q1 '22: 237.5M Q2 '22: 227.4M Q3 '22: 90.2M Q4 '22: 141M Q1 '23: 166.3M Q2 '23: 123.9M Q3 '23: 271.6M Q4 '23: 278.6M Q1 '24: 246.7M Q2 '24: 217.7M Q3 '24: 269.5M Q4 '24: 360.3M Q1 '25: 386.4M Q2 '25: 439.2M Q3 '25: 402.6M Q4 '25: 439.2M Q1 '26: 464.4M Q2 '26: 413.4M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '09: 101.5M Q3 '09: 102.2M Q1 '10: 108M Q2 '10: 108.2M Q3 '10: 108.3M Q1 '11: 109M Q2 '11: 109.5M Q3 '11: 109.2M Q1 '12: 108.7M Q2 '12: 108M Q3 '12: 108.1M Q1 '13: 107.1M Q2 '13: 99.8M Q3 '13: 100.4M Q1 '14: 100.9M Q2 '14: 100.6M Q3 '14: 100.5M Q1 '15: 101.1M Q2 '15: 101.5M Q3 '15: 101.5M Q1 '16: 99.4M Q2 '16: 99.4M Q3 '16: 99.4M Q1 '17: 99M Q2 '17: 98.9M Q3 '17: 99M Q1 '18: 99.4M Q2 '18: 99.6M Q3 '18: 100M Q1 '19: 99.7M Q2 '19: 99.3M Q3 '19: 99.4M Q1 '20: 99.6M Q2 '20: 99.9M Q3 '20: 99.9M Q1 '21: 100.2M Q2 '21: 100.2M Q3 '21: 100.2M Q1 '22: 100.2M Q2 '22: 100.3M Q3 '22: 100.5M Q1 '23: 100.9M Q2 '23: 101.1M Q3 '23: 101.4M Q1 '24: 102.2M Q2 '24: 102M Q3 '24: 102.1M Q1 '25: 102.1M Q2 '25: 102.3M Q3 '25: 102.3M Q1 '26: 100.6M Q2 '26: 100M Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.00 6.00 9.00 Q4 '10: 8.24 Q1 '11: 8.60 Q2 '11: 8.33 Q3 '11: 8.60 Q4 '11: 1.90 Q1 '12: 1.56 Q2 '12: 1.82 Q3 '12: 1.71 Q4 '12: 1.68 Q1 '13: 1.77 Q2 '13: 3.00 Q3 '13: 3.15 Q4 '13: 2.41 Q1 '14: 2.41 Q2 '14: 1.60 Q3 '14: 1.54 Q4 '14: 2.29 Q1 '15: 2.25 Q2 '15: 1.85 Q3 '15: 1.85 Q4 '15: 1.90 Q1 '16: 2.07 Q2 '16: 2.27 Q3 '16: 2.39 Q4 '16: 2.58 Q1 '17: 2.67 Q2 '17: 2.72 Q3 '17: 2.75 Q4 '17: 2.83 Q1 '18: 2.97 Q2 '18: 3.19 Q3 '18: 3.41 Q4 '18: 2.93 Q1 '19: 3.12 Q2 '19: 3.12 Q3 '19: 3.21 Q4 '19: 3.61 Q1 '20: 3.45 Q2 '20: 2.87 Q3 '20: 2.67 Q4 '20: 2.85 Q1 '21: 3.05 Q2 '21: 3.84 Q3 '21: 4.06 Q4 '21: 4.11 Q1 '22: 3.91 Q2 '22: 3.27 Q3 '22: 2.72 Q4 '22: 2.70 Q1 '23: 2.70 Q2 '23: 3.11 Q3 '23: 3.50 Q4 '23: 3.46 Q1 '24: 3.69 Q2 '24: 3.91 Q3 '24: 4.13 Q4 '24: 4.46 Q1 '25: 4.84 Q2 '25: 5.11 Q3 '25: 5.29 Q4 '25: 5.54 Q1 '26: 5.99 Q2 '26: 6.14 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.